PUBLICATIONS · 34644605
Hematopoietic Cell Transplantation after CD19 Chimeric Antigen Receptor T Cell-Induced Acute Lymphoblastic Lymphoma Remission Confers a Leukemia-Free Survival Advantage.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Transplant Cell Ther
- Publication date
- 2022 Jan
- First author
- Summers C
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Transplant Cell Ther. 2022 Jan;28(1):1-2. doi: 10.1016/j.jtct.2021.12.002.
- note
- Source null
- related pmid
- 35067350
- relationship
- Comment in
Authors and identifiers
- name
- Summers C
- type
- Author
- name
- Wu QV
- type
- Author
- name
- Annesley C
- type
- Author
- name
- Bleakley M
- type
- Author
- name
- Dahlberg A
- type
- Author
- name
- Narayanaswamy P
- type
- Author
- name
- Huang W
- type
- Author
- name
- Voutsinas J
- type
- Author
- name
- Brand A
- type
- Author
- name
- Leisenring W
- type
- Author
- name
- Jensen MC
- type
- Author
- name
- Park JR
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Summers C
- type
- Author
- name
- Wu QV
- type
- Author
- name
- Annesley C
- type
- Author
- name
- Bleakley M
- type
- Author
- name
- Dahlberg A
- type
- Author
- name
- Narayanaswamy P
- type
- Author
- name
- Huang W
- type
- Author
- name
- Voutsinas J
- type
- Author
- name
- Brand A
- type
- Author
- name
- Leisenring W
- type
- Author
- name
- Jensen MC
- type
- Author
- name
- Park JR
- type
- Author
- bibliography ids
- nci-bib-3a76746b0b3b05fd2954a8fa
- book metadata
- content sha256
- 1b880f69694485c9911434cd7350b228fa93feeb322fbac1b72bec885632fbd3
- document type
- citation
- dois
- 10.1016/j.jtct.2021.10.003
- electronic publication date
- display
- 2021 Oct 10
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:34644605
- immutable id
- pubmed:34644605@1b880f69694485c9911434cd7350b228fa93feeb322fbac1b72bec885632fbd3
- journal
- abbreviation
- Transplant Cell Ther
- issn electronic
- 2666-6367
- issn print
- Source null
- issue
- 1
- name
- Transplantation and cellular therapy
- nlm unique id
- 101774629
- pages
- 21-29
- volume
- 28
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Transplant Cell Ther. 2022 Jan;28(1):1-2. doi: 10.1016/j.jtct.2021.12.002.
- note
- Source null
- related pmid
- 35067350
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 34644605
- provenance
- batch id
- 192b6392c165c6b06274
- provider
- NCBI PubMed ESummary
- record sha256
- bdbcff8ae99bd0c600a40de95e2d7b94b46e5cfb7fff595d9d71d5baed60e6c9
- response sha256
- 7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
- retrieved at
- 2026-09-09T23:48:02.713075+00:00
- publication date
- display
- 2022 Jan
- precision
- month
- year
- 2022
- publication types
- Clinical Trial, Phase I
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Hematopoietic Cell Transplantation after CD19 Chimeric Antigen Receptor T Cell-Induced Acute Lymphoblastic Lymphoma Remission Confers a Leukemia-Free Survival Advantage.
Preserved source evidence · Not medical advice
Triangle